BAC
Bank of America Corporation
BAC has a slight edge over CFR overall, supported by stronger fundamentals and stronger modeled upside.
CFR
Cullen/Frost Bankers, Inc.
CFR's outlook is improving, though it still trails on the overall score.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
CFR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
CFR's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like CFR.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over CFR in the historical PE scenario, which offers more potential upside but is not a forecast.
CFR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 12x | $126 | -20% |
| Forward | 13x | $158 | — |
| Fair | 14x | $152 | -4% |
| Current | 15x | $158 | — |
| Expensive | 19x | $207 | +31% |
Historical ranges are pointers, not guarantees.
CFR's PE is 15x, but its earnings don't support one, so it isn't a reliable read right now.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
CFR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for CFR, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over CFR on earnings, with more consistent year-over-year improvement.
CFR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $11.91 | +11% |
| Q3 2026 | $10.75 | +11% |
| Q2 2026 | $10.58 | +14% |
| Q1 2026 | $10.27 | +13% |
| Q4 2025 | $9.92 | +12% |
| Q3 2025 | $9.72 | +21% |
| Q2 2025 | $9.29 | +13% |
| Q1 2025 | $9.11 | +7.7% |
| Q4 2024 | $8.87 | -2.5% |
CFR earned $10.75 per share over the past year, up 11% from the year before. Its recent earnings include one-off gains.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over CFR on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
CFR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $603.8M | +6.4% |
| Q2 2026 | $576M | +5.3% |
| Q1 2026 | $574.8M | +6.4% |
| Q4 2025 | $580.9M | +8.3% |
| Q3 2025 | $567.3M | +9.5% |
| Q2 2025 | $546.9M | +7.7% |
| Q1 2025 | $540.2M | +7.7% |
| Q4 2024 | $536.3M | +6.9% |
CFR's revenue has grown year over year for 10 quarters in a row: $604M last quarter, up 6.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 36% | -1.1 points |
| Q2 2026 | 36% | +1.4 points |
| Q1 2026 | 35% | +2.1 points |
| Q4 2025 | 34% | -0.2 points |
| Q3 2025 | 37% | +2.8 points |
| Q2 2025 | 34% | -0.4 points |
| Q1 2025 | 33% | +0.9 points |
| Q4 2024 | 34% | +10 points |
CFR has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
CFR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $248.7M | +17% |
| Q2 2026 | -$7.1M | -106% |
| Q1 2026 | $198.7M | +$535.8M |
| Q4 2025 | $138.2M | +419% |
| Q3 2025 | $211.7M | -25% |
| Q2 2025 | $114.5M | +11% |
| Q1 2025 | -$337.1M | -175% |
| Q4 2024 | $26.7M | +$150.2M |
CFR has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over CFR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
CFR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.5% | -338K shares |
| 1 year | -3.1% | -2M shares |
| 3 years | -3.3% | -2.1M shares |
| 5 years | -3.1% | -2M shares |
| Available history | -2.1% | -1.3M shares |
CFR has 62M diluted shares, down 3.1% from a year ago, with $264M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $15.2M |
| Q2 2026 | $90.9M |
| Q1 2026 | $72.3M |
| Q4 2025 | $85.4M |
| Q3 2025 | $69.8M |
| Q2 2025 | $76,000 |
| Q1 2025 | $2.6M |
| Q4 2024 | $8.6M |
CFR spent $264M buying back its own shares over the past year, about three times what it spent the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
CFR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.7x | Net Cash |
| Q2 2026 | -0.7x | Net Cash |
| Q1 2026 | -0.6x | Net Cash |
| Q4 2025 | -0.7x | Net Cash |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.8x | Net Cash |
| Q1 2025 | -0.8x | Net Cash |
| Q4 2024 | -0.8x | Net Cash |
CFR has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
CFR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.7 | Neutral |
| Stochastic | 44.9 | Neutral |
CFR's weekly RSI is 55 (neutral) and its Stochastic is 45 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over CFR on valuation relative to its sector.
CFR PE vs Financial Services Sector
| Metric | CFR | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 13% above |
| PE % | 56 | 63 | 7 pts below |
CFR is trading at 15x earnings, a 13% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
CFR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $155.7 | 1.4% above |
| 20 week MA | $159.8 | 1.2% below |
| 50 week MA | $146.8 | 7.5% above |
| 100 week MA | $137.4 | 15% above |
| 200 week MA | $123.3 | 28% above |
CFR has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
CFR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.0 | $87.5 | -11% |
| 2021 | $87.5 | $125.5 | +43% |
| 2022 | $125.5 | $131.7 | +5% |
| 2023 | $131.7 | $108.5 | -18% |
| 2024 | $108.5 | $135.2 | +25% |
| 2025 | $135.2 | $128.6 | -4.9% |
| 2026 YTD | $128.6 | $157.8 | +23% |
CFR has the edge over BAC on returns for 2026, with the stronger performance.